Archives of Clinical Infectious Diseases

Published by: Kowsar

Possible Link Between Toxoplasma gondii Infection and Mood Disorders in Lorestan Province, Western Iran

Farnaz Kheirandish 1 , Hedayat Nazari 2 , Hossein Mahmoudvand 1 , Yaser Yaseri 3 , Mohammad Javad Tarahi 4 , Shirzad Fallahi 1 and Behrouz Ezatpour 5 , *
Authors Information
1 Department of Medical Parasitology and Mycology, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, IR Iran
2 Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, IR Iran
3 School of Medicine, Lorestan University of Medical Sciences, Khorramabad, IR Iran
4 Department of Epidemiology and Biostatistics, School of Public Health, Lorestan University of Medical Sciences, Khorramabad, IR Iran
5 Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: October 01, 2016, 11 (4); e36602
  • Published Online: July 21, 2016
  • Article Type: Research Article
  • Received: January 25, 2016
  • Revised: July 2, 2016
  • Accepted: July 12, 2016
  • DOI: 10.5812/archcid.36602

To Cite: Kheirandish F, Nazari H, Mahmoudvand H, Yaseri Y, Tarahi M J, et al. Possible Link Between Toxoplasma gondii Infection and Mood Disorders in Lorestan Province, Western Iran, Arch Clin Infect Dis. 2016 ; 11(4):e36602. doi: 10.5812/archcid.36602.

Abstract
Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Dubey JP. Toxoplasmosis - a waterborne zoonosis. Vet Parasitol. 2004; 126(1-2): 57-72[DOI][PubMed]
  • 2. Mahmoudvand H, Saedi Dezaki E, Soleimani S, Baneshi MR, Kheirandish F, Ezatpour B, et al. Seroprevalence and risk factors of Toxoplasma gondii infection among healthy blood donors in south-east of Iran. Parasite Immunol. 2015; 37(7): 362-7[DOI][PubMed]
  • 3. Leroy V, Hadjichristodoulou C. Systematic review of risk factors for Toxoplasma gondii infection in pregnant women. 2005;
  • 4. Arab-Mazar Z, Zamanian MH, Yadegarynia D. Cerebral Toxoplasmosis in an HIV-Negative Patient: A Case Report. Arch Clin Infect Dis. 2016; 11(1)
  • 5. Fabiani S, Pinto B, Bonuccelli U, Bruschi F. Neurobiological studies on the relationship between toxoplasmosis and neuropsychiatric diseases. J Neurol Sci. 2015; 351(1-2): 3-8[DOI][PubMed]
  • 6. Prandovszky E, Gaskell E, Martin H, Dubey JP, Webster JP, McConkey GA. The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS One. 2011; 6(9)[DOI][PubMed]
  • 7. Mahmoudvand H, Ziaali N, Aghaei I, Sheibani V, Shojaee S, Keshavarz H, et al. The possible association between Toxoplasma gondii infection and risk of anxiety and cognitive disorders in BALB/c mice. Pathog Glob Health. 2015; 109(8): 369-76[DOI][PubMed]
  • 8. Mahmoudvand H, Ziaali N, Ghazvini H, Shojaee S, Keshavarz H, Esmaeilpour K, et al. Toxoplasma gondii Infection Promotes Neuroinflammation Through Cytokine Networks and Induced Hyperalgesia in BALB/c Mice. Inflammation. 2016; 39(1): 405-12[DOI][PubMed]
  • 9. Arab-Mazar Z, Seyyed-Tabaei SJ, Mirahmadi H. Cloning of dense granular (GRA) 7 gene of Toxoplasma gondii into pTZ57RT vectors for sub-cloning in prokaryotic and eukaryotic plasmids. Novel Biomed. 2014; 2(4): 114-9
  • 10. Arab-Mazar Z, Fallahi S, Koochaki A, Haghighi A, Seyyed Tabaei SJ. Immunodiagnosis and molecular validation of Toxoplasma gondii-recombinant dense granular (GRA) 7 protein for the detection of toxoplasmosis in patients with cancer. Microbiol Res. 2016; 183: 53-9[DOI][PubMed]
  • 11. Fallahi S, Mazar ZA, Ghasemian M, Haghighi A. Challenging loop-mediated isothermal amplification (LAMP) technique for molecular detection of Toxoplasma gondii. Asian Pac J Trop Med. 2015; 8(5): 366-72[DOI][PubMed]
  • 12. Fallahi S, Kazemi B, Seyyed tabaei SJ, Bandehpour M, Lasjerdi Z, Taghipour N, et al. Comparison of the RE and B1 gene for detection of Toxoplasma gondii infection in children with cancer. Parasitol Int. 2014; 63(1): 37-41[DOI][PubMed]
  • 13. Fallahi S, Seyyed Tabaei SJ, Pournia Y, Zebardast N, Kazemi B. Comparison of loop-mediated isothermal amplification (LAMP) and nested-PCR assay targeting the RE and B1 gene for detection of Toxoplasma gondii in blood samples of children with leukaemia. Diagn Microbiol Infect Dis. 2014; 79(3): 347-54[DOI][PubMed]
  • 14. The World Health Report 2001: Mental health: new understanding, new hope. 2001;
  • 15. Saxena S, Jane-Llopis E, Hosman C. Prevention of mental and behavioural disorders: implications for policy and practice. World Psychiatry. 2006; 5(1): 5-14[PubMed]
  • 16. Fekadu A, Shibre T, Cleare AJ. Toxoplasmosis as a cause for behaviour disorders--overview of evidence and mechanisms. Folia Parasitol (Praha). 2010; 57(2): 105-13[PubMed]
  • 17. Miman O, Mutlu EA, Ozcan O, Atambay M, Karlidag R, Unal S. Is there any role of Toxoplasma gondii in the etiology of obsessive-compulsive disorder? Psychiatry Res. 2010; 177(1-2): 263-5[DOI][PubMed]
  • 18. Torrey EF, Bartko JJ, Yolken RH. Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr Bull. 2012; 38(3): 642-7[DOI][PubMed]
  • 19. Dalimi A, Abdoli A. Latent toxoplasmosis and human. Iran J Parasitol. 2012; 7(1): 1
  • 20. Jung BK, Pyo KH, Shin KY, Hwang YS, Lim H, Lee SJ, et al. Toxoplasma gondii infection in the brain inhibits neuronal degeneration and learning and memory impairments in a murine model of Alzheimer's disease. PLoS One. 2012; 7(3)[DOI][PubMed]
  • 21. Badparva E, Kheirandish F, Ebrahimzade F. Prevalence of intestinal parasites in Lorestan Province, West of Iran. Asian Pac J Trop Dis. 2014; 4-32
  • 22. Kheirandish F, Badparva E, Haghighi A, Nazemalhosseini-Mojarad E, Kazemi B. Differential diagnosis of Entamoeba spp. in gastrointestinal disorder patients in Khorramabad, Iran. Afr J Microbiol Res. 2011; 5(18): 2863-6
  • 23. Kheirandish F, Sharafi AC, Kazemi B, Bandehpour M, Tarahi M, Khamesipour A. First molecular identification of Leishmania species in a new endemic area of cutaneous leishmaniasis in Lorestan, Iran. Asian Pac J Trop Med. 2013; 6(9): 713-7[DOI][PubMed]
  • 24. Kheirandish F, Chegeni Sharafi A, Kazemi B, Mohebali M, Sarlak A, Tarahi MJ, et al. Identification of leishmania species using PCR assay on giemsa-stained slides prepared from cutaneous leishmaniasis patients. Iran J Parasitol. 2013; 8(3): 382-8[PubMed]
  • 25. Kheirandish F, Tarahi M, Haghighi A, Nazemalhosseini-Mojarad E, Kheirandish M. Prevalence of intestinal parasites in bakery workers in khorramabad, lorestan iran. Iran J Parasitol. 2011; 6(4): 76-83[PubMed]
  • 26. Kheirandish F, Tarahi MJ, Ezatpour B. Prevalence of intestinal parasites among food handlers in Western Iran. Rev Inst Med Trop Sao Paulo. 2014; 56(2): 111-4[DOI][PubMed]
  • 27. Kheirandish F, Kayedi MH, Ezatpour B, Anbari K, Karimi Rouzbahani HR, Chegeni Sharafi A, et al. Seroprevalence of Human Fasciolosis in Pirabad, Lorestan Province, Western Iran. Iran J Parasitol. 2016; 11(1): 24-9[PubMed]
  • 28. Omrani VF, Fallahi S, Rostami A, Siyadatpanah A, Barzgarpour G, Mehravar S, et al. Prevalence of intestinal parasite infections and associated clinical symptoms among patients with end-stage renal disease undergoing hemodialysis. Infection. 2015; 43(5): 537-44[DOI][PubMed]
  • 29. Alipour A, Shojaee S, Mohebali M, Tehranidoost M, Abdi Masoleh F, Keshavarz H. Toxoplasma infection in schizophrenia patients: a comparative study with control group. Iran J Parasitol. 2011; 6(2): 31-7[PubMed]
  • 30. Ahmad D, Mehdi S, Sayed HH, Sayed AK, Shirzad G. Serological survey of Toxoplasma gondii in schizophrenia patients referred to Psychiatric Hospital, Sari City, Iran. Trop Biomed. 2010; 27(3): 476-82[PubMed]
  • 31. Mostafavi SN, Jalali Monfared L. Toxoplasmosis epidemiology in Iran: a systematic review. J Isfahan Med School. 2012; 176(30): 1-15
  • 32. Tavakoli Kareshk A, Keyhani A, Mahmoudvand H, Tavakoli Oliaei R, Asadi A, Andishmand M, et al. Efficacy of the Bunium persicum (Boiss) Essential Oil against Acute Toxoplasmosis in Mice Model. Iran J Parasitol. 2015; 10(4): 625-31[PubMed]
  • 33. Cetinkaya Z, Yazar S, Gecici O, Namli MN. Anti-Toxoplasma gondii antibodies in patients with schizophrenia--preliminary findings in a Turkish sample. Schizophr Bull. 2007; 33(3): 789-91[DOI][PubMed]
  • 34. Omar A, Bakar OC, Adam NF, Osman H, Osman A, Suleiman AH, et al. Seropositivity and serointensity of Toxoplasma gondii antibodies and DNA among patients with schizophrenia. Korean J Parasitol. 2015; 53(1): 29-34[DOI][PubMed]
  • 35. Khademvatan S, Saki J, Khajeddin N, Izadi-Mazidi M, Beladi R, Shafiee B, et al. Toxoplasma gondii Exposure and the Risk of Schizophrenia. Jundishapur J Microbiol. 2014; 7(11)[DOI][PubMed]
  • 36. Hamidinejat H, Ghorbanpoor M, Hosseini H, Alavi SM, Nabavi L, Jalali MH, et al. Toxoplasma gondii infection in first-episode and inpatient individuals with schizophrenia. Int J Infect Dis. 2010; 14(11)-81[DOI][PubMed]
  • 37. Cevizci S, Celik M, Akcali A, Oyekcin DG, Sahin OO, Bakar C. Seroprevalence of anti-Toxoplasma gondii and anti-Borrelia species antibodies in patients with schizophrenia: a case-control study from western Turkey. World J Biol Psychiatry. 2015; 16(4): 230-6[DOI][PubMed]
  • 38. Hamdani N, Daban-Huard C, Lajnef M, Richard JR, Delavest M, Godin O, et al. Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample. J Affect Disord. 2013; 148(2-3): 444-8[DOI][PubMed]
  • 39. Khademvatan S, Khajeddin N, Izadi S, Saki J. Study of Toxoplasma Gondii infection in patients with Bipolar disorder. J Med Sci. 2013; 13(3): 215
  • 40. Elsheikha HM, Azab MS, Abousamra NK, Rahbar MH, Elghannam DM, Raafat D. Seroprevalence of and risk factors for Toxoplasma gondii antibodies among asymptomatic blood donors in Egypt. Parasitol Res. 2009; 104(6): 1471-6[DOI][PubMed]
  • 41. Xiao Y, Yin J, Jiang N, Xiang M, Hao L, Lu H, et al. Seroepidemiology of human Toxoplasma gondii infection in China. BMC Infect Dis. 2010; 10: 4[DOI][PubMed]
  • 42. Yuksel P, Kocazeybek B, Alpay N, Babur C, Bayar R, Karaköse AR, et al. Establishing the Role of Latent Toxoplasmosis in the Ethiopathogenesis of Schizophrenia. Int J Infect Dis. 2008; 12
  • 43. Kolbekova P, Kourbatova E, Novotna M, Kodym P, Flegr J. New and old risk-factors for Toxoplasma gondii infection: prospective cross-sectional study among military personnel in the Czech Republic. Clin Microbiol Infect. 2007; 13(10): 1012-7[DOI][PubMed]
  • 44. Alvarado-Esquivel C, Mercado-Suarez MF, Rodriguez-Briones A, Fallad-Torres L, Ayala-Ayala JO, Nevarez-Piedra LJ, et al. Seroepidemiology of infection with Toxoplasma gondii in healthy blood donors of Durango, Mexico. BMC Infect Dis. 2007; 7: 75[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments